- Home
- WSO vs PODD Comparison
WSO vs PODD Comparison
Compare WSO & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSO
- PODD
- Stock Information
- Founded
- WSO 1945
- PODD 2000
- Country
- WSO United States
- PODD United States
- Employees
- WSO N/A
- PODD N/A
- Industry
- WSO Industrial Machinery/Components
- PODD Medical/Dental Instruments
- Sector
- WSO Consumer Discretionary
- PODD Health Care
- Exchange
- WSO Nasdaq
- PODD Nasdaq
- Market Cap
- WSO 19.1B
- PODD 16.5B
- IPO Year
- WSO N/A
- PODD 2007
- Fundamental
- Price
- WSO $497.85
- PODD $282.80
- Analyst Decision
- WSO Buy
- PODD Buy
- Analyst Count
- WSO 4
- PODD 16
- Target Price
- WSO $495.00
- PODD $291.81
- AVG Volume (30 Days)
- WSO 249.4K
- PODD 574.3K
- Earning Date
- WSO 02-18-2025
- PODD 02-20-2025
- Dividend Yield
- WSO 2.18%
- PODD N/A
- EPS Growth
- WSO N/A
- PODD 96.40
- EPS
- WSO 13.30
- PODD 5.78
- Revenue
- WSO $7,618,317,000.00
- PODD $2,071,600,000.00
- Revenue This Year
- WSO $4.49
- PODD $23.56
- Revenue Next Year
- WSO $6.36
- PODD $18.07
- P/E Ratio
- WSO $37.31
- PODD $48.93
- Revenue Growth
- WSO 4.59
- PODD 22.07
- 52 Week Low
- WSO $380.58
- PODD $160.19
- 52 Week High
- WSO $571.42
- PODD $289.46
- Technical
- Relative Strength Index (RSI)
- WSO 53.76
- PODD 54.94
- Support Level
- WSO $461.45
- PODD $270.00
- Resistance Level
- WSO $535.40
- PODD $288.95
- Average True Range (ATR)
- WSO 12.39
- PODD 6.83
- MACD
- WSO 4.47
- PODD -0.31
- Stochastic Oscillator
- WSO 49.37
- PODD 65.78
About WSO Watsco Inc.
Watsco is the largest heating, ventilation, air conditioning, and refrigeration products distributor in North America. The company primarily operates in the United States (90% of 2023 revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada (5% of sales) and Latin America (5% of sales). The company's customer base consists of more than 125,000 contractors that serve the replacement and new construction HVACR markets for residential and light commercial applications.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.